Skip to content
DraconiticResearch
Search Sources API
210,095 studies31 sourcesUpdated 37 min ago

Pharmacology & toxicology

3,072 studies265 in 7 days1,491 in 30 days

Filters
Type
Date
Clear

Latest

3,072 studies

  1. N-Ethylpentedrone: first hair detection and human metabolic profiling across multiple biological matrices using UHPLC-HRMS, molecular networking and in silico prediction
    Agathe Pasquet, Romain Pelletier, Roxane Rouah +5
    Archives of ToxicologyPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyHAL
  2. How PLGA Microspheres are Emerging as a Key Drug Delivery System
    Sai Qian, Lan Ma, Chenlu Liu +3
    International Journal of NanomedicinePeer-reviewedCC BY-NCFull text5 citedPharmacology & toxicologyOpenAlex
  3. Combinatorial treatment with formononetin and magnolol induces synergistic cytotoxicity and suppresses migration in glioblastoma cells
    Fatemh Dinarvand, Naghmeh Haddadi, Mohammad Zand Zand +1
    International Journal of Molecular and Cellular MedicinePeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyDOAJPMC
  4. Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes
    Yu-Nan Huang, Kai-Wen Liu, Pin-Hung Li +4
    Communications MedicinePeer-reviewedCC BYFull text1 citedPharmacology & toxicologyDOAJ
  5. Perchlorate supported anaerobic growth in Haloferax volcanii reveals a novel metabolic capability with implications for biosignature degradation
    Adam Robinson, Shannon McQuaig-Ulrich, Tyler Dondero +2
    Scientific ReportsPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  6. Hepatoprotective Activity of Ethyl Acetate and Methanol Extracts of Crotalaria biflora (Linn.) Whole Plant in Paracetamol-Induced Hepatotoxicity in Wistar Albino Rats
    Anoob Kumar KI, Swamivel Manickam, Sudhi BS +2
    International Journal of Research in Pharmaceutical SciencesPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  7. Three-dimensional green quantity (3DGQ) mapping and integrated 2D–3D assessment reveal hidden urban green deficits and inequities
    Shoubang Huang, Kai Zhou, Jingyi Han +4
    Journal of Environmental ManagementPeer-reviewedCC BY-NC-ND6 citedPharmacology & toxicologyOpenAlex
  8. Heat-related urban mortality attributable to human-induced climate change in Europe from 2000 to 2025
    Clair Barnes, Pierre Masselot, Di Xi +11
    Nature healthPeer-reviewedCC BYFull text1 citedPharmacology & toxicologyEurope PMCEurope PMCPMC
  9. Phytochemical Profiling, Characterisation, and Antibacterial Potential of Syzygium aromaticum (Clove) Extracts Against Multidrug-Resistant Bacterial Strains
    Amit Kumar, Jasveer Singh, Shiv Dutt +2
    International Journal of Research in Pharmaceutical SciencesPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  10. Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
    Ioana Rada Popa Ilie, Stéliana Ghibu, Anca Butucă +5
    PharmaceuticalsPeer-reviewedCC BY7 citedPharmacology & toxicologyOpenAlex
  11. Valorization of spent hops: a techno-economic analysis of bioactive extract production using conventional solvent and supercritical fluid extraction methods
    Micheli L. Monte, Bibiana Silva, Camila Kolling +5
    Journal of Cleaner ProductionPeer-reviewedCC BY5 citedPharmacology & toxicologyOpenAlex
  12. Oxidative Stress and Antioxidant Defense Mechanisms in Sepia esculenta Larvae Induced by Co-Exposure to Environmental Cadmium and Copper
    Xueyu Zhu, Xiaokai Bao, Mingzhi Guo +4
    AntioxidantsPeer-reviewedCC BY6 citedPharmacology & toxicologyOpenAlex
  13. Firearms, storage practices, and child blood lead levels and household dust lead loadings: findings from the HOME study
    Christian Hoover, Yingying Xu, Bruce Lanphear +3
    Journal of exposure science & environmental epidemiologyPeer-reviewedCC BY 4.0Full text1 citedPharmacology & toxicologyPMC
  14. Somatosensory Disturbance and Long‐Term Exposure to Methylmercury: A Comprehensive Review
    Leonardo Breno do Nascimento de Aviz, Carolina Fonte de Aviz, Fabiana Costa Cardoso +7
    Journal of Applied ToxicologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  15. Accelerating drug development in infectious diseases using zebrafish disease models supported by pharmacokinetic pharmacodynamic modeling as new approach methodology (NAM)
    G. Forn-Cuni, B. van Lieshout, B. Koch +11
    bioRxivPreprintCC BYFull text1 citedPharmacology & toxicologybioRxiv
  16. Occurrence and Health Risk Assessment of Organophosphate Esters in Seafood from Southeastern China: Impacts of Cooking Methods and Dietary Exposure.
    Yunshuang Liu, Qian Zou, Mei Liu +9
    Environment & health (Washington, D.C.)Peer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMC
  17. Facility-wide assessment of occupational exposure to dust, noise, and formaldehyde
    Emilio Molina Rueda, Ellison Carter, Christian L’Orange +8
    Journal of Exposure Science & Environmental EpidemiologyPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyPMC
  18. Clinical risk factors of licorice-induced pseudohyperaldosteronism: a 2026-updated narrative review
    Tetsuhiro Yoshino, Toshiaki Makino
    Frontiers in PharmacologyPeer-reviewedCC BYFull text6 citedPharmacology & toxicologyOpenAlex
  19. Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process
    Martin Plöderl, Mark Horowitz, Florian Naudet +2
    The International Journal of Risk & Safety in MedicinePeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMC
  20. Beyond the TCDD Lens in Paritutu/New Plymouth, New Zealand: Invisible Phenoxy-Herbicide Co-Contaminants, Visible Developmental Signals, and Decision-Making under Incomplete Evidence
    Andrew Gibbs
    Pollution and DiseasesPeer-reviewedCC BY8 citedPharmacology & toxicologyOpenAlex
  21. Study 12 — The COVID-19 Dexamethasone Programme as Real-World Validation of Corticosteroid-Strongyloides Risk
    Marcus Webb
    Zenodo (CERN European Organization for Nuclear Research)PreprintPublic domain5 citedPharmacology & toxicologyOpenAlex
  22. FAERS Pharmacovigilance: Strongyloides stercoralis Adverse Event Disproportionality in Corticosteroid Recipients
    Marcus Webb
    Zenodo (CERN European Organization for Nuclear Research)PreprintPublic domain8 citedPharmacology & toxicologyOpenAlex
  23. PCO371 intracellular agonism at the parathyroid hormone 1 receptor produces pan-activation of signalling partners
    F. Napier Khwaja, Z. Mariam, Y. Abdolhay +6
    bioRxivPreprintCC BY-NDFull textPharmacology & toxicologybioRxiv
  24. Forensic Tracing of Unknown Compounds at the Human–Environment Interface: An All-in-One LC–HRMS Strategy Guided by a Curated Methodological Database
    Alix Munoz, Jeanne Brotier, Laetitia Barthe +2
    ACS OmegaPeer-reviewedCC BY-NC-ND 4.0Full text1 citedPharmacology & toxicologyHAL
  25. Hierarchical Environmental Exposure Transforms Zeolitic Imidazolate Framework-8 and Increases Toxicity in Daphnia magna
    Swaroop Chakraborty, Iuliia Mikulska, Rhiannon E. Boseley +9
    ACS NanoPeer-reviewedCC BY5 citedPharmacology & toxicologyOpenAlex